Ratio of bcl-xshort to bcl-xlong is different in good- and poor- prognosis subsets of acute myeloid leukemia

Molecular Medicine

Volumn 4, Issue 3, 1998, Pages 158-164

  Deng, G ^a   Lane, C ^a   Kornblau, S ^a   Goodacre, A ^a   Snell, V ^a   Andreeff, M ^a   Deisseroth, A B ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER SURVIVAL; CHROMOSOME INVERSION; HUMAN; HUMAN CELL; MONOSOMY; PRIORITY JOURNAL;

EID: 0031950241     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401913     Document Type: Article

References (30)

1. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. (1995) Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 9: 965-971.
2. Walker H, Smith FJ, Betts DR. (1994) Cytogenetics in acute myeloid leukemia. Blood Rev. 8: 30-36.
3. Maseki N, Miyoshi H, Shimizu K, Homma C, Ohki M, Sakurai M, Kaneko Y. (1993) The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood 81: 1573-1579.
4. Symes PH, Williams ME, Flessa HC, Srivastava AK, Swerdlow SH. (1993) Acute promyelocytic leukemia with the pseudo-Chediak-Higashi anomaly and molecular documentation of t(15; 17) chromosomal translocation. Am. J. Clin. Pathol. 99: 622-627.
5. Hoffmann L, Moller P, Pedersen BJ, Waage A, Pedersen M, Hirsch FR. (1995) Therapy-related acute promyelocytic leukemia with t(15;17)(q22; q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Ann. Oncol. 6: 781-788.
6. Baranger L, Baruchel A, Leverger G, Schaison G, Berger R. (1990) Monosomy-7 in childhood hemopoietic disorders. Leukemia 4: 345-349.
7. Stephenson J, Lizhen H, Mufti GJ. (1995) Possible co-existence of RAS activation and monosomy 7 in the leukemic transformation of myelodysplastic syndromes. Leuk. Res. 19: 741-748.
8. Vogler WR. (1992) Strategies in the treatment of acute myelogenous leukemia. Leuk. Res. 16: 1143-1148.
9. Downing JR, Head DR, Curcio BA, et al. (1993) An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 81: 2860-2865.
10. Lo CF, Diverio D, D'Adamo F, Avvisati G, Alimena G, Nanni M, Alcalay M, Pandolfi PP, Pelicci PG. (1992) PML/RAR-alpha rearrangement in acute promyelocytic leukemias apparently lacking the t(15;17) translocation. Eur. J. Haematol. 48: 173-177.
11. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW. (1994) Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 8: 1533-1538.
12. de Greef G, Hagemeijer A, Morgan R, Wijsman J, Hoefsloot LH, Sandberg AA, Sacchi N. (1995) Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia. Leukemia 9: 282-288.
13. Reed JC. (1995) Bcl-2 family proteins: regulators of chemoresistance in cancer. Toxicol. Lett. 155: 82-84.
14. Korsmeyer SJ. (1995) Regulators of cell death. Trends Genet. 11: 101-105.
15. Craig RW. (1995) The bcl-2 gene family. Semin. Cancer Biol. 6: 35-43.
16. Yin XM, Oltval ZN, Korsmeyer SJ. (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [see comments]. Nature 369: 321-323.
17. Boise LH, Gonzalez GM, Postema CE, et al. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
18. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 90: 3516-3520.
19. Miyashita T, Reed JC. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
20. Park JR, Bernstein ID, Hockenbery DM. (1995) Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86: 868-876.
21. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736.
22. Farrow SN, White JH, Martinou I, et al. (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-733.
23. Karsan A, Yee E, Kaushansky K, Harlan JM. (1996) Cloning of human bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089-3096.
24. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ. (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739.
25. Lin EY, Orlofsky A, Berger MS, Prystowsky MB. (1993) Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979-1988.
26. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291.
27. Maung ZT, MacLean FR, Reid MM, Pearson AD, Proctor SJ, Hamilton PJ, Hall AG. (1994) The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Br. J. Haematol 88: 105-109.
28. Keith FJ, Bradbury DA, Zhu YM, Russell NH. (1995) Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to ara-C. Leukemia 9: 131-138.
29. Minn AJ, Rudin CM, Boise LH, Thompson C. (1995) Expression of bcl-xl can confer a multidrug resistance phenotype. Blood 86: 1903-1910.
30. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G, Castle VP. (1995) Bcl-xl is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis, Cancer Res. 55: 2576-2582.